Past events

Following a successful AXS24 Summit, Asembia is excited to be planning next year’s conference comprising networking sessions, exhibits and more. Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.

The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.

The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. This conference provides a forum to discuss and advance orphan drug development and enhance access to life-saving therapies for individuals living with a rare disease.

The Start-to-Finish of Vaccines from research, immune profiling & clinical trials to manufacture and access.

Europe's premier conference in the cell and gene therapy industry today.

This two day course is your fast track to mastering the current use of the most powerful AI tools in market access. You'll gain practical insights and expert advice on applying AI effectively and confidently in your market access role.

Over 1000 of the world's leading pharma changemakers from commercial, marketing, medical affairs, patient engagement, market access, RWE, and digital health are gathering under one roof in Barcelona. At this event, together, we will become the trusted source for scientific information, transform digital potential into meaningful patient outcomes, adapt to the incoming JCA legislation and harness growing data sources that will deliver value to customers and growing patient population needs.

As medical studies are used extensively in interactions with pharma stakeholders, it is important that everyone in the medical affairs team understands the statistical concepts and data presented in these studies. More importantly, they need to be able to critically evaluate the building blocks of a statistical analysis to ensure that study findings are leveraged correctly and most effectively. By attending this course, you will develop the following skills: Insightful statistical thinking; learn to look beyond the numbers and understand their real-world significance. Critical analysis abilities: Assess the robustness and relevance of statistical methods used in medical studies. Effective communication of statistics: Translate statistical findings into accurate and compelling narratives for various stakeholders.

Achieving success in a pharma licensing negotiation process hinges on meticulous management of each step involved. Apart from knowing the theoretical framework, one must also gain significant practical expertise to ensure favourable outcomes. Learn from an industry expert and gain hands-on experience in realistic scenarios that accurately replicate the intricacies of the BioPharma sector.

By attending this 2-day course you will quickly get up the learning curve and know how to apply AI most effectively and efficiently in your pharma marketing role. You will not only have the chance to ask your specific questions to a true AI-Pharma Marketing expert, but also benefit from the unique opportunity to share experiences and engage in in-depth discussions with your international peers.

In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise: High R&D Attrition Rates, Extended Investment Cycles and Complex IP Landscapes. This hands-on introductory course equips you with practical valuation tools essential for Financing rounds and investment decisions, Mergers & Acquisitions (M&A), Licensing deals and partnerships, Strategic development planning, Portfolio optimisation.

To ensure you are ready to navigate your company/brands towards successful commercial launch in the US, a first step is to grasp the fundamental structure and dynamics of US market access. Secondly, you need to foresee the potential routes to successful market access and how to deal with the most common market access challenges. This course will give you all of that in just 1 day.

Achieving global commercial launch success requires an early start—beginning as early as proof of concept—along with specialised expertise and seamless cross-functional collaboration. This course equips you with all the concepts, evidence-based tools, and strategic insights to make informed decisions and effectively plan every step towards a successful global launch.

Attending this course is a crucial investment for leaders and key contributors in a country launch team because it offers comprehensive insights and practical tools to manage successful product launches.

This 2-day workshop is designed for innovative marketing and sales staff who want to enhance customer-centricity through the selective adoption of digital in their communication with HCPs, patients, caregivers

NICE is celebrating 25 years of independence, transparency and rigour which have earned it a globally respected reputation. The NICE Conference 2025 will explore our continued commitment to deliver relevant, timely and impactful guidance. The event brings together frontline staff and leaders from health and care together with the life sciences, healthtech and digital sectors, to explore how NICE continues to transform to meet the rapidly changing needs of the system.

Real World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs) to further reduce regulatory, payer, physician and patient uncertainty. Unfortunately, many companies struggle implementing it. The key ingredient to success is a cross-functional organisation where managers have widespread knowledge of the fundamentals and a shared vocabulary. In this course you will learn the fundamentals of RWE so that you can contribute effectively when decisions are made and/or when implementing RWE studies.

This two-day programme equips you with important concepts, tools, and techniques that increase the impact of the Medical Affairs role, be it as a manager of teams or as a key contributor in cross-functional teams.

The goal of this course is to demystify market access for anyone involved. By participating, you will not only have the chance to ask your specific questions to a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers. Additionally, you will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource to reference in your daily work.

This one-day programme empowers Commercial and Medical Affairs managers to become highly effective contributors to the cross-functional process required for a successful omnichannel pharma brand launch.